Recent Activity

Loading...

BIB

ProShares Ultra Nasdaq Biotechnology · NAS

  • Category Equity
  • Expense Ratio 0.95%
  • Listing Date Apr 08, 2010
  • Volume 10,286.0
  • Market Cap (AUM) $89.31M

Performance

+8.94%

1W

+2.73%

1M

-2.03%

3M

+20.62%

6M

-3.6%

YTD

-2.65%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • United States Treasury Bills 0.0% 08-AUG-2024N/A16.89%
  • U.S. DollarN/A12.62%
  • Amgen Inc.AMGN5.97%
  • Regeneron Pharmaceuticals, Inc.REGN5.70%
  • Vertex Pharmaceuticals IncorporatedVRTX5.59%
  • Gilead Sciences, Inc.GILD5.32%
  • Moderna, Inc.MRNA3.60%
  • Astrazeneca PLC Sponsored ADRAZN3.31%
  • Biogen Inc.BIIB2.33%
  • Illumina, Inc.ILMN1.48%

Technical Analysis of BIB 2024-05-03

Overview:

In analyzing the technical indicators for BIB stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the upcoming days.

Trend Indicators:

  • Moving Averages (MA): The 5-day Moving Average (MA) has been consistently ab...
See more ...

Recent News & Updates